Subjective perceptions of patients undergoing radioiodine therapy: why should we know about them? Lutz S. FreudenbergStefan P. MüllerAndreas Bockisch Editorial 13 June 2009 Pages: 1743 - 1744
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) C. ChiesaF. BottaE. Bombardieri Original Article 20 May 2009 Pages: 1745 - 1757
Effects of therapy with [177Lu-DOTA0,Tyr3]octreotate on endocrine function Jaap J. M. TeunissenEric P. KrenningDik J. Kwekkeboom Original Article Open access 27 May 2009 Pages: 1758 - 1766
Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice Christoph G. U. RieseStephan SeitzThomas M. Behr Original Article 16 May 2009 Pages: 1767 - 1773
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma K. StrobelB. BodeG. K. von Schulthess Original Article 04 June 2009 Pages: 1774 - 1782
Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse Chun-Ta LiaoJoseph Tung-Chieh ChangTzu-Chen Yen Original Article 04 June 2009 Pages: 1783 - 1793
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity Jeong Won LeeBom Sahn KimWon Jun Kang Original Article 09 May 2009 Pages: 1794 - 1802
Skeletal metastases: what is the future role for nuclear medicine? Gary J. R. Cook Editorial Commentary 13 August 2009 Pages: 1803 - 1806
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT Stefan KrügerAndreas K. BuckSven N. Reske Original Article 06 June 2009 Pages: 1807 - 1812
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation? Pierre Y. SalaunThomas GastinneFrançoise Kraeber-Bodéré Original Article 05 June 2009 Pages: 1813 - 1821
Scintigraphic visualization of bacterial translocation in experimental strangulated intestinal obstruction Yu. M. GaleevYu. B. LishmanovO. V. Salato Short Communication 13 May 2009 Pages: 1822 - 1828
Diagnostic pathway of integrated SPECT/CT for coronary artery disease Riemer H. J. A. SlartRene A. TioRudi A. Dierckx Editorial 13 June 2009 Pages: 1829 - 1834
Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease Tsuguru HattaShigeyuki NishimuraTsunehiko Nishimura Original Article 28 May 2009 Pages: 1835 - 1841
Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT Stefano MuzzarelliMatthias Emil PfistererMichael Johannes Zellweger Original Article 27 May 2009 Pages: 1842 - 1850
Neuropsychological functions and rCBF SPECT in Parkinson’s disease patients considered candidates for deep brain stimulation Anna PaschaliLambros MessinisPaulos Vassilakos Original Article 27 May 2009 Pages: 1851 - 1858
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184 Svante NybergMaria Eriksdotter JönhagenLars Farde Short Communication Open access 05 June 2009 Pages: 1859 - 1863
Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging Thuy A. TranDaniel RosikVladimir Tolmachev Original Article 06 June 2009 Pages: 1864 - 1873
99mTcO(MAG2-3G3-dimer): a new integrin αvβ3-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics Jiyun ShiLijun WangShuang Liu Original Article 30 May 2009 Pages: 1874 - 1884
Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER Akihiro TakanoBalázs GulyásChrister Halldin Short Communication 30 June 2009 Pages: 1885 - 1891
Recent advances in the assessment of myocardial viability Giovanni LucignaniAlberto Cuocolo Focus On... 01 September 2009 Pages: 1892 - 1895
A different role for FDG PET/CT in axillary lymph node staging in breast cancer Tjeerd S. AukemaMarieke E. StraverWouter V. Vogel Letter to the Editor 25 July 2009 Pages: 1896 - 1897
Reply to the Letter “A different role of FDG PET/CT for axillary lymph node staging in breast cancer” Till A. HeusnerSherko KuemmelAlexander R. Stahl Letter to the Editor 25 July 2009 Pages: 1898 - 1899
Monitoring of systemic candidiasis by 18F-FDG PET/CT John Avet Jr.Denise GranjonFrancis Dubois Image of the Month 01 September 2009 Pages: 1900 - 1900
Intractable hiccups causing avid FDG uptake in the muscles of respiration Yi-Tung T. HuangSally F. BarringtonPaul A. Thomas Image of the Month 01 September 2009 Pages: 1901 - 1901
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma Lee W. T. AlkureishiZeynep BurakThe European Association of Nuclear Medicine (EANM) Oncology Committee and European Sentinel Node Biopsy Trial (SENT) Committee Guidelines Open access 26 September 2009 Pages: 1915 - 1936
